Thrombin_NN
and_CC
thrombin_NN
receptor_NN
agonist_NN
peptide_NN
induce_VBP
early_JJ
events_NNS
of_IN
T_NN
cell_NN
activation_NN
and_CC
synergize_VBP
with_IN
TCR_NN
cross-linking_NN
for_IN
CD69_NN
expression_NN
and_CC
interleukin_NN
2_CD
production_NN
._.

Thrombin_NN
stimulation_NN
of_IN
the_DT
T_NN
leukemic_JJ
cell_NN
line_NN
Jurkat_NN
induced_VBD
a_DT
transient_JJ
increase_NN
in_IN
-LCB-_-LRB-
Ca2_NN
+_NN
-RCB-_-RRB-
i_RB
._.

Proteolytic_JJ
activity_NN
of_IN
the_DT
enzyme_NN
was_VBD
required_VBN
for_IN
this_DT
effect_NN
since_IN
diisopropyl_NN
fluorophosphate-thrombin_NN
failed_VBD
to_TO
increase_NN
-LCB-_-LRB-
Ca2_NN
+_NN
-RCB-_-RRB-
i_NN
._.

Furthermore_RB
,_,
hirudin_NN
and_CC
anti-thrombin_NN
III_CD
inhibited_VBD
the_DT
thrombin-induced_JJ
-LCB-_-LRB-
Ca2_NN
+_NN
-RCB-_-RRB-
i_NN
rise_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

A_DT
synthetic_JJ
thrombin_NN
receptor_NN
agonist_NN
peptide_NN
-LRB-_-LRB-
TRP_NN
-RRB-_-RRB-
of_IN
7_CD
residues_NNS
-LRB-_-LRB-
SFLLRNP_NN
-RRB-_-RRB-
was_VBD
found_VBN
to_TO
be_VB
as_IN
effective_JJ
as_IN
thrombin_NN
for_IN
-LCB-_-LRB-
Ca2_NN
+_NN
-RCB-_-RRB-
i_VBG
mobilization_NN
,_,
and_CC
both_DT
agonists_NNS
induced_VBD
Ca2_NN
+_CC
release_NN
exclusively_RB
from_IN
internal_JJ
stores_NNS
._.

Thrombin_NN
stimulated_VBD
tyrosine_NN
phosphorylation_NN
of_IN
several_JJ
proteins_NNS
of_IN
molecular_JJ
mass_NN
40_CD
,_,
42_CD
,_,
70_CD
,_,
120_CD
,_,
and_CC
130_CD
kDa_NN
._.

There_EX
was_VBD
a_DT
good_JJ
correlation_NN
between_IN
thrombin-induced_JJ
tyrosine_NN
phosphorylation_NN
of_IN
the_DT
latter_JJ
three_CD
proteins_NNS
and_CC
Ca2_NN
+_CC
mobilization_NN
._.

Thrombin_NN
and_CC
TRP_NN
also_RB
caused_VBD
translocation_NN
of_IN
protein_NN
kinase_NN
C_NN
from_IN
the_DT
cytosol_NN
to_TO
the_DT
plasma_NN
membrane_NN
._.

As_IN
a_DT
likely_JJ
consequence_NN
of_IN
these_DT
events_NNS
,_,
thrombin_NN
activated_VBD
the_DT
nuclear_JJ
factor_NN
NF-kB_NN
._.

Several_JJ
cell_NN
lines_NNS
of_IN
hematopoietic_JJ
origin_NN
including_VBG
the_DT
leukemic_JJ
T_NN
cell_NN
line_NN
HPB_NN
._.
ALL_NN
and_CC
the_DT
erythroleukemic_JJ
cell_NN
line_NN
K562_NN
were_VBD
responsive_JJ
to_TO
thrombin_NN
,_,
whereas_IN
others_NNS
such_JJ
as_IN
THP1_NN
,_,
a_DT
myelomonocytic_JJ
cell_NN
line_NN
,_,
and_CC
BL2_NN
,_,
a_DT
Burkitt_NN
lymphoma_NN
were_VBD
refractory_JJ
to_TO
thrombin_NN
or_CC
TRP_NN
stimulation_NN
._.

The_DT
magnitude_NN
of_IN
the_DT
thrombin_NN
response_NN
in_IN
the_DT
different_JJ
cell_NN
types_NNS
paralleled_VBD
the_DT
expression_NN
of_IN
the_DT
thrombin_NN
receptor_NN
mRNA_NN
._.

We_PRP
found_VBD
that_IN
activation_NN
of_IN
Jurkat_NN
T_NN
cells_NNS
by_IN
a_DT
combination_NN
of_IN
phytohemagglutinin_NN
and_CC
phorbol_NN
12-myristate_NN
13-acetate_NN
led_VBD
to_TO
a_DT
dramatic_JJ
inhibition_NN
of_IN
thrombin_NN
receptor_NN
mRNA_NN
expression_NN
and_CC
to_TO
a_DT
concomitant_JJ
loss_NN
of_IN
the_DT
thrombin_NN
response_NN
._.

Finally_RB
,_,
we_PRP
demonstrate_VBP
that_IN
thrombin_NN
and_CC
TRP_NN
enhanced_VBD
CD69_NN
expression_NN
and_CC
interleukin_NN
2_CD
production_NN
induced_VBN
by_IN
T_NN
cell_NN
receptor_NN
cross-linking_NN
in_IN
both_CC
Jurkat_NN
T_NN
cells_NNS
and_CC
peripheral_JJ
blood_NN
lymphocytes_NNS
._.

These_DT
findings_NNS
highlight_VBP
the_DT
role_NN
of_IN
thrombin_NN
as_IN
a_DT
potential_JJ
regulator_NN
of_IN
T_NN
lymphocyte_NN
activation_NN
._.

